Antibiotic allergy

New England Journal of Medicine

Volumn 354, Issue 6, 2006, Pages 601-609

  Gruchalla, Rebecca S ^a   Pirmohamed, Munir ^b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CEFTAZIDIME; CELECOXIB; CEPHALOSPORIN; CLAVULANIC ACID; CLINDAMYCIN; COTRIMOXAZOLE; DAPSONE; DIURETIC AGENT; DRUG ANTIBODY; IMMUNOGLOBULIN E ANTIBODY; MACROLIDE; MINOCYCLINE; PENICILLIN G; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFAMETHOXAZOLE; SULFONAMIDE; SULFONYLUREA DERIVATIVE; TETRACYCLINE; THIOACETAZONE; TICARCILLIN; VANCOMYCIN; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; PENICILLIN DERIVATIVE;

ALLERGIC VASCULITIS; ANAMNESIS; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIBIOTIC THERAPY; ANTIBODY DETECTION; APLASTIC ANEMIA; ARTICLE; BRONCHOSPASM; CELLULITIS; CHILL; CHOLESTATIC HEPATITIS; CLINICAL EXAMINATION; CLINICAL FEATURE; CROSS REACTION; CYSTIC FIBROSIS; CYTOPENIA; DELAYED HYPERSENSITIVITY; DESENSITIZATION; DIAGNOSTIC TEST; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; EOSINOPHILIA; ERYTHEMA; ERYTHEMA MULTIFORME; EXFOLIATIVE DERMATITIS; HEMOLYSIS; HEMOLYTIC ANEMIA; HOT FLUSH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERPIGMENTATION; HYPOTENSION; IMMUNE COMPLEX DISEASE; IMMUNE RESPONSE; INFECTIOUS MONONUCLEOSIS; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; LIVER INJURY; LUNG INFILTRATE; LYMPHOCYTE TRANSFORMATION TEST; MACULOPAPULAR RASH; MEASLES LIKE RASH; MYOCARDITIS; NEPHROTOXICITY; PENICILLIN ALLERGY; PHOTOSENSITIVITY DISORDER; POLYARTERITIS NODOSA; PRIORITY JOURNAL; PRURITUS; RESPIRATORY TRACT INFECTION; SERUM SICKNESS; SKIN TEST; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VESICULAR RASH; ALGORITHM; CHEMICALLY INDUCED DISORDER; FEMALE; IMMEDIATE TYPE HYPERSENSITIVITY; MIDDLE AGED; REVIEW;

ALGORITHMS; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MIDDLE AGED; PENICILLINS; SKIN TESTS; SULFONAMIDES; URTICARIA;

EID: 32144450428     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcp043986     Document Type: Article

References (56)

1. Bigby M, Jick S, Jick H, Arndt K. Drug-induced cutaneous reactions: a report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 1986;256:3358-63.
2. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-5.
3. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ 2004;329:15-9.
4. Fiszenson-Albala F, Auzerie V, Mahe E, et al. A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol 2003;149:1018-22.
5. Park BK, Pirmohamed M, Kitteringham NR. Role of drug disposition in drug hypersensitivity: a chemical, molecular, and clinical perspective. Chem Res Toxicol 1998;11:969-88.
6. Schnyder B, Mauri-Hellweg D, Zanni M, Bettens F, Pichler WJ. Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alpha/beta T cell clones. J Clin Invest 1997;100:136-41.
7. Weltzien HU, Padovan E. Molecular features of penicillin allergy. J Invest Dermatol 1998;110:203-6.
8. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003;139:683-93.
9. Adkinson NF Jr. Drug allergy. In: Adkinson NF Jr, Yunginger J, Busse W, Bochner B, Holgate S, Simons F, eds. Middleton's allergy: principles and practice. Philadelphia: Mosby, 2003:1679-94.
10. Lee CE, Zembower TR, Fotis MA, et al. The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance. Arch Intern Med 2000;160:2819-22.
11. Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK. Adverse drug reactions. BMJ 1998;316:1295-8.
12. Sullivan JR, Shear NH. The drug hypersensitivity syndrome: what is the pathogenesis? Arch Dermatol 2001;137:357-64.
13. Pirmohamed M, Kitteringham NR, Park BK. The role of active metabolites in drug toxicity. Drug Saf 1994;11:114-44.
14. Rudolph AH, Price EV. Penicillin reactions among patients in venereal disease clinics: a national survey. JAMA 1973;223:499-501.
15. Pirmohamed M, Park BK. HIV and drug allergy. Curr Opin Allergy Clin Immunol 2001;1:311-6.
16. van der Ven AJAM, Koopmans PP, Vree TB, van der Meer JW. Adverse reactions to co-trimoxazole in HIV infection. Lancet 1991;338:431-3.
17. Farrell J, Naisbitt DJ, Drummond NS, et al. Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans. J Pharmacol Exp Ther 2003;306:229-37.
18. Wills R, Henry RL, Francis JL. Antibiotic hypersensitivity reactions in cystic fibrosis. J Paediatr Child Health 1998;34:325-9.
19. Burrows JA, Toon M, Bell SC. Antibiotic desensitization in adults with cystic fibrosis. Respirology 2003;8:359-64.
20. Andersen Lund B, Bergan T. Temporary skin reactions to penicillins during the acute stage of infectious mononucleosis. Scand J Infect Dis 1975;7:21-8.
21. Pullen H, Wright N, Murdoch JM. Hypersensitivity reactions to antibacterial drugs in infectious mononucleosis. Lancet 1967;2:1176-8.
22. Levy M. Role of viral infections in the induction of adverse drug reactions. Drug Saf 1997;16:1-8.
23. Nazareth I, Mortimer P, McKendrick GD. Ampicillin sensitivity in infectious mononucleosis - temporary or permanent? Scand J Infect Dis 1972;4:229-30.
24. Gruchalla RS. Clinical assessment of drug-induced disease. Lancet 2000;356:1505-11.
25. [Erratum, Lancet 2001;357:724.]
26. Mori K, Maru C, Takasuna K. Characterization of histamine release induced by fluoroquinolone antibacterial agents in vivo and in vitro. J Pharm Pharmacol 2000;52:577-84.
27. Veien M, Szlam F, Holden JT, Yamaguchi K, Denson DD, Levy JH. Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells. Anesthesiology 2000;92:1074-81.
28. Litt JZ. Litt's drug eruption reference manual: including drug interactions. 10th ed. London: Taylor & Francis, 2004.
29. Empedrad R, Darter AL, Earl HS, Gruchalla RS. Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics. J Allergy Clin Immunol 2003;112:629-30.
30. Bernstein I, Gruchalla RS, Lee R, Nicklas R, Dykewicz M. Executive summary of disease management of drug hypersensitivity: a practice parameter. Ann Allergy Asthma Immunol 1999;83:665-700.
31. Gadde J, Spence M, Wheeler B, Adkinson NF Jr. Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA 1993;270:2456-63.
32. Mendelson LM, Ressler C, Rosen JP, Selcow JE. Routine elective penicillin allergy skin testing in children and adolescents: study of sensitization. J Allergy Clin Immunol 1984;73:76-81.
33. Sogn DD, Evans R III, Shepherd GM, et al. Results of the National Institute of Allergy and Infectious Diseases Collaborative Clinical Trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults. Arch Intern Med 1992;152:1025-32.
34. Lin RY. A perspective on penicillin allergy. Arch Intern Med 1992;152:930-7.
35. Macy E, Mangat R, Burchette RJ. Penicillin skin testing in advance of need: multiyear follow-up in 568 test result-negative subjects exposed to oral penicillins. J Allergy Clin Immunol 2003;111:1111-5.
36. Malakar S, Dhar S, Shah Malakar R. Is serum sickness an uncommon adverse effect of minocycline treatment? Arch Dermatol 2001;137:100-1.
37. Ordoqui E, Zubeldia J, Aranzabal A, et al. Serum tryptase levels in adverse drug reactions. Allergy 1997;52:1102-5.
38. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004;59:809-20.
39. Messaad D, Sahla H, Benahmed S, Godard P, Bousquet J, Demoly P. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004;140:1001-6.
40. Solensky R. Drug desensitization. Immunol Allergy Clin North Am 2004;24:425-43.
41. Naclerio R, Mizrahi E, Adkinson NF Jr. Immunologic observations during desensitization and maintenance of clinical tolerance to penicillin. J Allergy Clin Immunol 1983;71:294-301.
42. Turvey SE, Cronin B, Arnold AD, Dioun AF. Antibiotic desensitization for the allergic patient: 5 years of experience and practice. Ann Allergy Asthma Immunol 2004;92:426-32.
43. Carr A, Penny R, Cooper DA. Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients. AIDS 1993;7:65-71.
44. Rich JD, Sullivan T, Greineder D, Kazanjian PH. Trimethoprim/ sulfamethoxazole incremental dose regimen in human immunodeficiency virus-infected persons. Ann Allergy Asthma Immunol 1997;79:409-14.
45. Saxon A, Beall GN, Rohr AS, Adelman DC. Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med 1987;107:204-15.
46. Kelkar PS, Li JT. Cephalosporin allergy. N Engl J Med 2001;345:804-9.
47. Pumphrey RS, Davis S. Under-reporting of antibiotic anaphylaxis may put patients at risk. Lancet 1999;353:1157-8.
48. Lieberman P, Kemp S, Oppenheimer J, Lang D, Bernstein I, Nicklas R. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol 2005;115:Suppl:S483-S523.
49. Solensky R, Earl HS, Gruchalla RS. Penicillin allergy: prevalence of vague history in skin test-positive patients. Ann Allergy Asthma Immunol 2000;85:195-9.
50. Brackett CC, Singh H, Block JH. Likelihood and mechanisms of cross-allergenicity between sulfonamide antibiotics and other drugs containing a sulfonamide functional group. Pharmacotherapy 2004;24:856-70.
51. Knowles S, Shapiro L, Shear NH. Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of 'sulfa' allergy. Drug Saf 2001;24:239-47.
52. Strom B, Schinnar R, Apter A, et al. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med 2003;349:1628-35.
53. O'Donohue J, Oien KA, Donaldson P, et al. Co-amoxiclav jaundice: clinical and histological features and HLA class II association. Gut 2000;47:717-20.
54. Romano A, De Santis A, Romito A, et al. Delayed hypersensitivity to aminopenicillins is related to major histocompatibility complex genes. Ann Allergy Asthma Immunol 1998;80:433-7.
55. Macy E. Multiple antibiotic allergy syndrome. Immunol Allergy Clin North Am 2004;24:533-43.
56. Warrington R. Multiple drug allergy syndrome. Can J Clin Pharmacol 2000;7:18-9.